ARS PHARMACEUTICALS
ARS Pharmaceuticals is a stealth pharmaceutical company that developed a novel intranasal epinephrine spray with a unique absorption technology that could be easy-to-use, convenient, and more reliable for patients and loved ones at risk of severe allergic reactions to food, medications and insect bites that could lead to life-threatening anaphylaxis.
ARS PHARMACEUTICALS
Industry:
Biopharma Health Care Medical Pharmaceutical
Founded:
2015-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.ars-pharma.com
Total Employee:
11+
Status:
Active
Contact:
858-335-1300
Total Funding:
75 M USD
Technology used in webpage:
Euro CrUX Top 50m Common Name Invalid Amazon Route 53 Slider Revolution Elementor Pro Google Cloud Global Multi-Region Mailgun EmbedPress FEEDZY RSS Feeds
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Alara Gateway
The medical imaging gateway built for cloud-native workflows
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Marius Pharmaceuticals
Marius Pharmaceuticals is a biopharmaceutical company that brings novel treatments to a range of diseases with unmet medical needs.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-11-08 | Silverback Therapeutics | Silverback Therapeutics acquired by ARS Pharmaceuticals | N/A |
Investors List
SR One
SR One investment in Series D - ARS Pharmaceuticals
Deerfield
Deerfield investment in Series D - ARS Pharmaceuticals
RA Capital Management
RA Capital Management investment in Series D - ARS Pharmaceuticals
Deerfield
Deerfield investment in Series C - ARS Pharmaceuticals
Key Employee Changes
Official Site Inspections
http://www.ars-pharma.com Semrush global rank: 594.06 K Semrush visits lastest month: 54.23 K
- Host name: 249.110.215.35.bc.googleusercontent.com
- IP address: 35.215.110.249
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "ARS Pharmaceuticals"
Meet Our Team – ARS Pharma
ARS Pharmaceuticals is dedicated to transforming the treatment of severe allergic reactions. Our mission is to develop innovative, patient-friendly and easy-to-use treatments that empower …See details»
ARS Pharma – Developing Biotechnology
At ARS Pharma, we are committed to developing patient-friendly treatments to address serious issues related to needle-related risks, device portability and ease of use. Our innovative …See details»
Leadership – ARS Pharma
Dr. Robert Bell is the Chief Scientific Officer of ARS Pharmaceuticals, Inc. He brings more than 30 years of multidisciplinary experience in strategic global business development, (more…)See details»
ARS Pharmaceuticals - Crunchbase Company Profile
ARS Pharmaceuticals is a stealth pharmaceutical company that specializes in developing anti allergy drugs.See details»
Org Chart ARS Pharmaceuticals - The Official Board
The org chart of ARS Pharmaceuticals contains its 19 main executives including Richard Lowenthal, Kathleen Scott and Brian Dorsey.See details»
ARS Pharmaceuticals Operations, Inc. - Drug pipelines, Patents ...
Explore ARS Pharmaceuticals Operations, Inc. with its drug pipeline, therapeutic area, technology platform, 11 news, Disease Domain:Immune System Diseases, Infectious ...See details»
Investors - ARS Pharmaceuticals
Mar 5, 2025 The Investor Relations website contains information about ARS Pharmaceuticals's business for stockholders, potential investors, and financial analysts.See details»
Investors - ARS Pharmaceuticals
Corporate Profile ARS Pharmaceuticals is dedicated to empowering at-risk patients and caregivers to better protect themselves from severe allergic reactions that could lead to …See details»
ARS Pharm - Overview, News & Similar companies | ZoomInfo.com
Apr 17, 2024 View ARS Pharm (www.ars-pharma.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as employees …See details»
ARS Pharma Company Profile - Office Locations, Competitors
Oct 29, 2024 ARS Pharma has 5 employees at their 1 location and $30 k in annual revenue in FY 2023. See insights on ARS Pharma including office locations, competitors, revenue, …See details»
Richard Lowenthal – ARS Pharma
He has served as past chair of the American Association of Pharmaceutical Scientists (San Diego region), as well as member of the USP Biotechnology Expert Committee, Virology Working group, member of the National …See details»
Mission, Vision & Core Values of ARS Pharmaceuticals
Dec 19, 2024 ARS Pharmaceuticals Mission, Vision & Core Values At ARS Pharmaceuticals, our mission is to revolutionize the healthcare industry by providing innovative and life-saving …See details»
ARS Pharmaceuticals Reports Fourth Quarter and Full Year 2024 …
6 days ago Under the terms of the licensing agreement, ARS Pharma holds the option to repurchase rights to certain regions partnered to ALK.See details»
ARS Pharmaceuticals, Inc. - 10K - Annual Report - March 20, 2025
Mar 20, 2025 Item 1. Business. As used in this Annual Report, unless the context indicates or otherwise requires, “ARS,” “ARS Pharma,” the “company,” “we,” “us,” “our,” and other similar …See details»
ARS Pharmaceuticals Inc Company Profile - Overview - GlobalData
ARS Pharmaceuticals Inc (ARS Pharma) is a biopharmaceutical company that develops the treatments for severe allergic reactions. The company's main product in development is a …See details»
ARS Pharmaceuticals Reports Fourth Quarter and Full Year 2024 …
SAN DIEGO, March 20, 2025 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and …See details»
ARS Pharmaceuticals - News, Articles etc. - European …
17 October 2024 | By Dr Sarina Tanimoto (ARS Pharmaceuticals) Dr Sarina Tanimoto, MBA, Co-Founder and Chief Medical Officer of ARS Pharmaceuticals, discusses the company’s …See details»
ARS Pharma Retakes Its 50-Day Line In Bullish Post-Earnings …
6 days ago Shares of ARS Pharmaceuticals (SPRY) bounded off their 50-day line Thursday after the biotech company reported an unexpected fourth-quarter profit and better-than-expected …See details»
Board of Directors - ARS Pharma
Our Board of Directors is charged both with guiding our company and advocating on behalf of the patients and caregivers we serve.See details»
ARS Pharmaceuticals Expands Executive Leadership Team with …
SAN DIEGO, Feb. 9, 2022 /PRNewswire/ -- ARS Pharmaceuticals, Inc., a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves …See details»